Pay in 4 interest-free payments of $7.18 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Meritain Health requires the member to complete an appeals form to indicate a request for external review
Unfortunately, despite scientific evidence to the contrary, obesity is often seen as a lifestyle choice something that people should manage themselves, said Dr
Solaun, East Coast sales director for Enzymedica
Published clinical guidelines from organizations including the American Society of Metabolic and Bariatric Surgery and the Obesity Medicine Association have identified GLP-1 receptor agonists as appropriate pharmacological interventions in patients with a BMI of 30 or above (classified as obesity), or BMI of 27 or above with at least one weight-related comorbidity such as type 2 diabetes, hypertension, dyslipidemia, or obstructive sleep apnea - the same criteria framework used by the FDA in evaluating GLP-1 medications for their obesity management indications
Clin Liver Dis 2004;8:501-519
US$ 22.51
US$ 26.67
US$ 29.30
